Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice

European Journal of Pharmacology

Volumn 311, Issue 1, 1996, Pages 7-14

  Teixeira, Raquel M ^a   Santos, Adair R S ^a   Ribeiro, Sandro J ^a   Calixto, João B ^a   Rae, Giles A ^a   De Lima, Thereza C M ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Anxiety; FK 888; Intracerebroventricular injection; Neurokinin A; Plus maze; SR 48968; Substance P; Tachykinin NK1 receptor; Tachykinin NK2 receptor

Indexed keywords

4 ETHYL 6,7 DIMETHOXY BETA CARBOLINE 3 CARBOXYLIC ACID METHYL ESTER; DIAZEPAM; N BENZYL N2 [4 HYDROXY 1 [(1 METHYL 1H INDOL 3 YL)CARBONYL]PROLYL] N METHYL 3 (2 NAPHTHYL)ALANINAMIDE; NEUROKININ DERIVATIVE; PENTETRAZOLE; SAREDUTANT; SUBSTANCE P; TACHYKININ RECEPTOR AGONIST; TACHYKININ RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANQUILIZING ACTIVITY;

EID: 0030571026     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00390-1     Document Type: Article

References (43)

1. Almay, B.G., F. Johansson, L. Von Knorring, P. Le Greves and L. Terenius, 1988, Substance P in CSF of patients with chronic pain syndrome, Pain 33, 3.
2. Couture, R., S. Boucher, P. Picard and D. Regoli, 1993, Receptor characterization of the spinal action of neurokinins on nociception: a three receptor hypothesis, Reg. Pept. 46, 426.
3. Cuello, A.C. and I. Kanazawa, 1978, The distribution of substance P immunoreactive fibers in the rat central nervous system, J. Comp. Neurol. 178, 129.
4. Davis, M., 1992, The role of amygdala in fear and anxiety, Annu. Rev. Neurosci. 15, 353.
5. Duham, N.W. and T.S. Miya, 1957, A note on a simple apparatus for detecting neurological deficit in rats and mice, J. Am. Pharm. Assoc. 46, 208.
6. 2) receptor, Life Sci. 50, 101.
7. 1 receptor antagonist, FK 888, Br. J. Pharmacol. 107, 785.
8. Geyer, M.A., P.V. Russo and V.L. Masten, 1986, Multivariate assessment of locomotor behavior: pharmacological and behavioral analyses, Pharmacol. Biochem. Behav. 25, 277.
9. Graeff, F.G., 1994, Neuroanatomy and neurotransmitter regulation of defensive behaviors and related emotions in mammals, Braz. J. Med. Biol. Res. 27, 811.
10. Griebel, G., J.-L. Moreau, F. Jenck, J.R. Martin and R. Misslin, 1993, Some critical determinants of the behaviour of rats in the elevated plus-maze, Behav. Proc. 29, 37.
11. Hagan, R.M., S.J. Ireland, C.C. Jordan, I.J. Beresford, M.J. Deal and P. Ward, 1991, Receptor-selective, peptidase-resistant agonists at tachykinin NK-1 and NK-2 receptors: new tools for investigating tachykinin function, Neuropeptides 19, 127.
12. Haley, T.J. and W.G. McCormick, 1957, Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse, Br. J. Pharmacol. 12, 12.
13. Harro, J., E. Vasar and J. Bradwejn, 1993, CCK in animal and human research on anxiety, Trends Pharmacol. Sci. 14, 244.
14. Huston, J.P. and R.U. Hasenöhrl, 1995, The role of neuropeptides in learning: focus on the tachykinin substance P, Behav. Brain Res. 66, 117.
15. Itoi, K., N. Jost, C. Tschope, J. Culman, E. Badoer and T. Unger, 1994, Inhibition by morphine of the cardiovascular and behavioral responses evoked by centrally administered substance P in conscious, Neuropharmacology 33, 181.
16. Johansson, O., T. Hökfelt, B. Pernow, S.L. Jeffcoate, N. White, H.W.M. Steinbusch, A.A.J. Verhofstad, P.C. Emson and E. Spindel, 1981, Immunohistochemical support for three putative transmitters in one neuron: coexistence of 5-hydroxytryptamine, substance P-and thyrotropin releasing hormone-like immunoreactivity in medullary neurons projecting to the spinal cord, Neuroscience 6, 1857.
17. 2-terminus of substance P in the inhibition by capsaicin of behavioral sensitization to kainic acid-induced activity in the adult mouse, J. Pharmacol. Exp. Ther. 268, 366.
18. Laursen, S.E. and J.K. Belknap, 1986, Intracerebroventricular injections in mice. Some methodological refinements, J. Pharmacol. Meth. 16, 355.
19. Le Bars, D., S. Bourgoin, A.M. Clot, M. Hamom and F. Cesselin, 1987, Noxious mechanical stimuli increase the release of Met-enkephalin-like material heterosegmentally in the rat spinal cord, Brain Res. 402, 188.
20. Lister, R.G., 1987, The use of plus-maze to measure anxiety in the mouse, Psychopharmacology 92, 180.
21. Maggi, C.A., 1995, The mammalian tachykinin receptors, Gen. Pharmacol. 26, 911.
22. Otsuka, M. and M. Yanagisawa, 1990, Pain and neurotransmitters, Cell Mol. Neurobiol. 10, 293.
23. Otsuka, M. and K. Yoshioka, 1993, Neurotransmitter functions of mammalian tachykinins, Physiol. Rev. 73, 229.
24. Pellow, S., P. Chopin, S.E. File and M. Briley, 1985, Validation of open:closed arms entries in an elevated plus-maze as a measure of anxiety in the rat, J. Neurosci. Meth. 14, 149.
25. Picard, P., D. Regoli and R. Couture, 1994, Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists, Br. J. Pharmacol. 112, 240.
26. Pokk, P. and A. Zharkovsky, 1995, The effects of drugs acting at GABA-benzodiazepine-barbiturate receptor complex on the behaviour of sleep-deprived mice, Pharmacol. Toxicol. 76, 23.
27. 2 receptors antagonists, Med. Res. Rev. 15, 139.
28. Ravard, S., J. Betschart, V. Fardin, O. Flamand and J.C. Blanchard, 1994, Differential ability of tachykinin NK-1 and NK-2 agonists to produce scratching and grooming behaviours in mice, Brain Res. 651, 199.
29. Regoli, D., A. Boudon and J.L. Fauchere, 1994, Receptors and antagonists for substance P and related peptides, Pharmacol. Rev. 46, 551.
30. Rodgers, R.J. and J.C. Cole, 1994, The elevated plus-maze: pharmacology, methodology and ethology, in: Ethology and Psychopharmacology, eds. S.J. Cooper and C.A. Hendrie (John Wiley and Sons Ltd.) p. 9.
31. 2 tachykinin receptor, Peptides 10, 593.
32. Rosen, A., J. Franck and E. Brodin, 1995, Effects of acute systemic treatment with the 5-HT-uptake blocker alaproclate on tissue levels and release of substance P in rat periaqueductal grey, Neuropeptides 28, 317.
33. Rupniak, N.M.J. and A.R. Williams, 1994, Differential inhibition of foot tapping and chomadacryorrhoea in gerbils by CNS penetrant and non-penetrant tachykinin NK1 receptor antagonists, Eur. J. Pharmacol. 265, 179.
34. Saija, A., C. Polidori, M. Massi, M. Perfumi, G. De Caro and G. Costa, 1989, Label distribution after infection of labelled tachykinins into the rat lateral cerebroventricle, Res. Commun. Chem. Pathol. Pharmacol. 64, 99.
35. Shaikh, M.B. and A. Siegel, 1994, Neuronatomical and neurochemical mechanisms underlying amygdaloid control of defensive rage behavior in the cat, J. Med. Biol. Res. 27, 2759.
36. Shephard, R.A., 1986, Neurotransmitters, anxiety and benzodiazepines: a behavioral review, Neurosci. Biobehav. Rev. 10, 449.
37. 2 receptor antagonists in the mouse light-dark box, Eur. J. Pharmacol. 250, 11.
38. Treit, D., J. Menard and C. Royan, 1993, Anxiogenic stimuli in the elevated plus-maze, Pharmacol. Biochem. Behav. 44, 463.
39. 2 receptor antagonist, in rodent and primate models of anxiety, Psychopharmacology 121, 186.
40. Watson, S.P., B.E.B. Sandberg, M.R. Handley and L.L. Iversen, 1983, Tissue selectivity of substance P alkylesters suggesting multiple receptors, Eur. J. Pharmacol. 87, 77.
41. Yaksh, T.L., T.M. Jessel, R. Gamse, A.W. Mudge and S.E. Leeman, 1980, Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivo, Nature 286, 155.
42. Zangrossi, H., Jr. and F.G. Graeff, 1994, Behavioral effects of intra-amygdala injections of GABA and 5-HT acting drugs in the elevated plus-maze, Braz. J. Med. Biol. Res. 27, 2453.
43. Zernig, G., H. Dietrich, C.A. Maggi and A. Saria, 1992, The substance P (NK1) receptor antagonists (±)-CP-96,345 causes sedation and motor impairment of Swiss albino mice in the black-and-white box behavioral paradigm, Neurosci. Lett. 143, 169.